Nektar Therapeutics | NKTR - Market Capitalization


Nektar Therapeutics reported $10.9B in Market Capitalization this June of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
Agios Pharmaceuticals USD 2.01B 423M Mar/2026
ALKERMES USD 5.88B 1.26B Mar/2026
Alterity Therapeutics Limited AUD 36M 20M Jun/2026
Amgen USD 189.89B 13.64B Mar/2026
Baxter International USD 8.67B 1.15B Mar/2026
BioCryst Pharmaceuticals USD 1.66B 64M Dec/2025
Biogen USD 26.9B 1.09B Mar/2026
Bristol-Myers Squibb USD 123.83B 14.02B Mar/2026
Cara Therapeutics USD 366M 338M Sep/2025
Cipla INR 988.89B 231.9B Mar/2026
Dr.Reddys Laboratories INR 1.04T 13.7B Mar/2026
Eisai JPY 1.42T 110.62B Mar/2026
Eli Lilly USD 869.02B 146.97B Mar/2026
Esperion Therapeutics USD 885M 351M Dec/2025
Exelixis USD 10.89B 857M Mar/2026
Gilead Sciences USD 172.99B 20.71B Mar/2026
GlaxoSmithKline GBP 83.8B 9.44B Mar/2026
Halozyme Therapeutics USD 7.66B 257M Mar/2026
Incyte USD 18.73B 660M Mar/2026
Ionis Pharmaceuticals USD 12.46B 356M Mar/2026
Karyopharm Therapeutics USD 1.05B 912M Jun/2026
Merck USD 297.1B 35.84B Mar/2026
Nektar Therapeutics USD 11.91B 11.05B Jun/2026
Neurocrine Biosciences USD 13.25B 890M Mar/2026
Novartis USD 307.76B 15.54B Mar/2026
Pfizer USD 153.81B 12.24B Mar/2026
Roche Holding CHF 266.34B 55.46B Dec/2025
Sarepta Therapeutics USD 2.28B 30M Mar/2026
Takeda JPY 9.01T 1.37T Mar/2026
Teva Pharmaceutical Industries USD 34.27B 2.14B Mar/2026
Xencor USD 893M 200M Mar/2026